News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

Nouveau Marché gets first IPO in three years

Immuno-Designed Molecules, the cancer treatment specialist, plans to test the Nouveau Marché in the first significant flotation for three years. UBS is leading the deal.

The float comes amid a difficult market for initial public offerings and weak support for the biotechnology sector.

WSJ Logo